Penumbra (PEN) Net Margin Growth (3y) (2017 - 2026)
Penumbra (PEN) Net Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 300.00 |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 168.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 168.00 |
| Mar 31, 2026 | 515.00 |
| Dec 31, 2025 | 1,053.00 |
| Sep 30, 2025 | 1,399.00 |
| Jun 30, 2025 | 1,512.00 |
| Mar 31, 2025 | 1,206.00 |
| Dec 31, 2024 | 2,275.00 |
| Sep 30, 2024 | 557.00 |
| Jun 30, 2024 | -2,461.00 |
| Mar 31, 2024 | -251.00 |
| Dec 31, 2023 | 1,747.00 |
| Sep 30, 2023 | 994.00 |
| Jun 30, 2023 | 1,952.00 |
| Mar 31, 2023 | 290.00 |
| Dec 31, 2022 | -465.00 |
| Sep 30, 2022 | -895.00 |
| Jun 30, 2022 | -1,388.00 |
| Mar 31, 2022 | -810.00 |
| Dec 31, 2021 | -1,743.00 |
| Sep 30, 2021 | 2,346.00 |